Furthermore, the overexpression of solute carrier family 39 member 1 (SLC39A1) in renal cancer cells, specifically in the OSRC‐2 cell line, resulted in a significant downregulation of Lac‐Phe levels [91]. This evidence concerns the gene SLC39A1 and renal carcinoma.